Loading…
This entity appears on both sides of lobbying disclosures. The firm tab shows registrant-reported income; the client tab shows client-reported lobbying spend. Contract awards are separate and are not included here.
Lobbying Spend
$18K
Filings
16
Firms Hired
2
Active Period
2023–2025
Client-reported lobbying expenses on LDA filings
Lobbying firms retained by this client; amounts are client-reported expenses when available
Government entities explicitly identified as targets in LDA filings
Most frequently reported lobbying issues
Bill numbers found in source-reported LDA specific issue text; broad topic matches are excluded
To prohibit the use of Federal funds to implement, administer, or enforce a final rule of the Food and Drug Administration relating to "Medical Devices; Laboratory Developed Tests", and for other purposes.
2025 · first_quarter · Firm: GABBERT CONSULTING CO LLC
Supported HR 1463 a bill that restricts funding for FDA's LDT ruling
Client expense: — · Firm income: $9,000
Matched citations: HR 1463
Saving Access to Laboratory Services Act
2024 · fourth_quarter · Firm: GABBERT CONSULTING CO LLC
CMS Reimbursement Cuts/ HR 2377 Saving Access to Laboratory Services Act This bill modifies provisions relating to Medicare payment rates for clinical diagnostic laboratory services, including by requiring payment rates for certain widely available clinical diagnostic laboratory tests to be based on a statistical sampling of private sector rates.
Client expense: — · Firm income: $9,000
Matched citations: HR 2377
Saving Access to Laboratory Services Act
2024 · third_quarter · Firm: GABBERT CONSULTING CO LLC
CMS Reimbursement Cuts/ HR 2377 Saving Access to Laboratory Services Act This bill modifies provisions relating to Medicare payment rates for clinical diagnostic laboratory services, including by requiring payment rates for certain widely available clinical diagnostic laboratory tests to be based on a statistical sampling of private sector rates.
Client expense: — · Firm income: $9,000
Matched citations: HR 2377
Saving Access to Laboratory Services Act
2024 · second_quarter · Firm: GABBERT CONSULTING CO LLC
CMS Reimbursement Cuts/ HR 2377 Saving Access to Laboratory Services Act This bill modifies provisions relating to Medicare payment rates for clinical diagnostic laboratory services, including by requiring payment rates for certain widely available clinical diagnostic laboratory tests to be based on a statistical sampling of private sector rates.
Client expense: — · Firm income: $9,000
Matched citations: HR 2377
Saving Access to Laboratory Services Act
2024 · first_quarter · Firm: GABBERT CONSULTING CO LLC
CMS Reimbursement Cuts/ HR 2377
Client expense: — · Firm income: $9,000
Matched citations: HR 2377
Saving Access to Laboratory Services Act
2024 · first_quarter · Firm: GABBERT CONSULTING CO LLC
CMS Reimbursement Cuts/ HR 2377
Client expense: — · Firm income: —
Matched citations: HR 2377
Saving Access to Laboratory Services Act
2023 · fourth_quarter · Firm: GABBERT CONSULTING CO LLC
CMS Reimbursement Cuts/ HR 2377
Client expense: — · Firm income: $9,000
Matched citations: HR 2377
Saving Access to Laboratory Services Act
2023 · fourth_quarter · Firm: GABBERT CONSULTING CO LLC
CMS Reimbursement Cuts/ HR 2377
Client expense: — · Firm income: —
Matched citations: HR 2377
Saving Access to Laboratory Services Act
2023 · third_quarter · Firm: GABBERT CONSULTING CO LLC
CMS Reimbursement Cuts/ HR 2377
Client expense: — · Firm income: —
Matched citations: HR 2377
Source: Senate LDA